Mochida Pharmaceutical News

Convertible Stock List (Part 2) [Parabolic Signal Convertible Stock List]

○ List of sales conversion stocks market code stock name closing price SAR Tokyo Stock Exchange Prime ＜1720＞ Tokyu Construction 801 855 ＜1801＞ Taiseiken 5512 6015 ＜1802＞ Obayashi Corporation 1677 1780 ＜1803＞ Shimizu 949 1050 ＜1808＞ Haseko 1845 19

Fisco JapanMay 14 06:53

Mochida Pharmaceutical Sees FY Net Y5.60B

Mochida Pharmaceutical Co. Ltd. also released the following forecasts: GROUP Year Ending Mar 2025 Revenue Y106.00 bln Operating Profit Y7.50 bln P

Dow JonesMay 13 13:01

Express News | Mochida Pharm 2023/24 Group Net Profit 4.55 Bln Yen (-31.6 %), 2024/25 Forecast Profit 5.60 Bln Yen (+23.1 %)

BreakingsMay 13 13:00

Express News | Mochida Pharm 2023/24 Group Operating Profit 5.80 Bln Yen (-31.8 %), 2024/25 Forecast Profit 7.50 Bln Yen (+29.3 %)

BreakingsMay 13 13:00

Mochida Pharmaceutical: Consolidated Financial Results for the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)

Futu NewsMay 13 13:00 · Announcements

Taiseiken, Obayashi Corporation, Toray, Shiono Yoshi (13th) (1417-5070)

*The above calendar is just a schedule and is subject to change due to company circumstances. ---------------------------------------5/13 (Mon) ＜1417＞Miraite One ＜1435＞Robohome＜146A＞Colombia ＜1515＞Nippon Steel Mining ＜1518＞Mitsui Matsushima HD ＜1663＞K&O Energy＜167A＞Ryosan Ryoyo ＜1736＞Autech ＜174

Fisco JapanMay 13 05:30

Convertible Stock List (Part 1) [Parabolic Signal Convertible Stock List]

○ Purchase conversion stock list market code stock name closing price SAR Tokyo Stock Exchange Prime ＜2053＞ Chubu Feed 1173 1080 ＜2109＞ DM Mitsui Sugar 3025 2937 ＜2266＞ Rokko Butter 1453 1395 ＜2294＞ Kakiyasu Main Store 3180 3090 ＜2590＞ dyDo 　 　 　 　

Fisco JapanApr 23 07:03

List of Unrivaled Stocks (Part 2) [Ichimoku Equilibrium Chart/Kumoku Stock List]

○List of Unbroken Stocks Market Code Stock Name Closing Price Advance Span A Advance Span B Tokyo Stock Exchange Prime ＜1414＞ Show Bond 6292 6345.25 6375.5 ＜1719＞ Ando Hazama 1165 1215.25 1170.5 ＜1726＞ Br. HD 363 376.25 367 ＜1893＞

FiscoApr 3 06:45

Convertible Stock List (Part 3) [Parabolic Signal Convertible Stock List]

○ List of sales conversion stocks market code stock name closing price SAR Tokyo Stock Exchange Prime ＜2922＞ Natori 2114 2179 ＜2931＞ Euglena 605 641 ＜3002＞ Gunze 5420 5680 ＜3036＞ Alconix 1435 1496 ＜3087＞ Doutor Day Less 　 　 　

FiscoMar 29 06:53

List of Unrivaled Stocks (Part 1) [Ichimoku Equilibrium Chart/Kumoku Stock List]

○Kumojo Stock List Market Code Stock Name Closing Price Advance Span A Advance Span B Tokyo Stock Exchange Prime ＜3445＞ RS Techno 3015 2824 2900 ＜7989＞ Tachikawa Bly 1476 1472.25 1446 ○Kumo Gobble Stock List Market Code Stock Name Closing Price Leading Span A Advance Span B TSE Fly

FiscoMar 29 06:48

List of Yunlou stocks [Ichimoku equilibrium table/ Yunlou stock list]

○Kumo Stock List Market Code Stock Name Closing Price Advance Span A Preceding Span B Tokyo Stock Exchange Prime ＜1808＞ Haseko 1926 1902 1885 ＜2288＞ Marudaishoku 1659 1654.75 1628.5 ＜2335＞ Cubesys 1124 1117.5 1105.5 ＜2502＞ Asa

FiscoMar 28 06:37

Mochida Pharmaceutical Cuts FY Net View to Y4.40B

GROUP New Forecast Prior For Year To Mar 2024 Forecast Revenue Y102.00 bln Y104.00 bln Operating Profit Y5.50 bln

Dow JonesFeb 5 13:00

Mochida Pharmaceutical 1H Net Y2.84B Vs Net Y3.92B

Mochida Pharmaceutical Co. Ltd. (4534.TO) Japan 1st Half Ended September 30 GROUP 2023 2022 Revenue Y49.48 bln Y53.20 bln Operating Profit Y3.95 b

Dow JonesNov 2, 2023 13:00

Mochida Pharmaceutical 1Q Net Y1.69B Vs Net Y3.16B

Mochida Pharmaceutical Co. Ltd. (4534.TO) Japan 1st Quarter Ended June 30 GROUP 2023 2022 Revenue Y24.75 bln Y27.69 bln Operating Profit Y2.52 bln

Dow JonesAug 4, 2023 13:00

Mochida Pharmaceutical's Fiscal Full-Year Profit Falls 37.1%

Mochida Pharmaceutical's (TYO:4534) profit attributable to owners slipped 37.1% to 6.65 billion yen for the fiscal year ended March 31, compared with 10.57 billion yen a year ago. Basic net income per

MT NewswiresMay 16, 2023 12:42

Mochida Pharmaceutical Sees FY Net Y6.30B

Mochida Pharmaceutical Co. Ltd. also released the following forecasts: GROUP Year Ending Mar 2024 Revenue Y104.00 bln Operating Profit Y8.50

Dow JonesMay 15, 2023 13:01

Mochida Pharmaceutical 9-Mos Net Y8.08B Vs Net Y10.18B

Mochida Pharmaceutical Co. Ltd. (4534.TO) Japan Nine Months Ended December 31 GROUP 2022 2021 Revenue Y81.39 bln Y84.81 bln Operating Profit

Dow JonesFeb 6, 2023 13:03